The European Medicines Agency is preparing to make more of its documentaion available to health professionals and the general public. The policy can be seen at www.ema.europa.eu <http://www.ema.europa.eu/>BMJ 2010, 341, c7039
European parliament has passed draft legislation to allow drug companies to provide information directly to patients. The draft legislation would enable patients in the EU to receive data on a drug’s characteristic and the disease and condition for which it is designed. It claims to guarantee that the information provided would not stray into advertising. EU Governments have to approve this legislation before it can take effect.
BMJ 2010, 341, c6883
Powered by WordPress